[News] RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - Printable Version +- Apnea Board Forum - CPAP | Sleep Apnea (https://www.apneaboard.com/forums) +-- Forum: Public Area (https://www.apneaboard.com/forums/Forum-Public-Area) +--- Forum: Main Apnea Board Forum (https://www.apneaboard.com/forums/Forum-Main-Apnea-Board-Forum) +--- Thread: [News] RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS (/Thread-News-RECALL-THREAD-IMPORTANT-PHILIPS-DREAMSTATION-SYSTEM-ONE-USERS) Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
|
RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - ripnationstates - 09-28-2023 this is terrible news RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - btreger - 09-30-2023 Post-Gazette, ProPublica Sue FDA for records related to Philips's recall of breathing machines The Pittsburgh Post-Gazette and ProPublica have filed suit against the U.S. Food and Drug Administration in federal court in New York, accusing the agency of holding back records related to the sweeping recall of breathing machines sold worldwide. The FDA regulates the medical device industry and categorizes the recall as Class 1, reserved for defects that can cause severe harm or death. But the agency denied multiple requests by the news organizations to quickly release documents under the Freedom of Information Act, including the company’s prior test reports on the degrading foam and monthly updates by Philips about the status of a recall that has impacted millions of people in the United States and other countries. Post-Gazette, ProPublica sue FDA for records related to Philips CPAP recall | Pittsburgh Post-Gazette RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - btreger - 09-30-2023 PITTSBURGH POST-GAZETTE How we investigated the Philips CPAP recall To understand the breakdowns that led to one of the most tumultuous medical device recalls in generations, the Pittsburgh Post-Gazette and ProPublica spent a year probing what happened inside Philips Respironics after the company first learned that contaminants were turning up in breathing machines designed to save lives. Reporters for the two news outlets collaborated with NRC Media in Amsterdam, where Philips’ parent company, Royal Philips, is headquartered, as well as with student journalists from Northwestern University’s Medill Investigative Lab. Reporters obtained newly unsealed court documents, internal emails, text messages, and public records in the United States and other countries to track Philips’ and its parent company’s response to the problem. Those documents included records from four tests conducted by independent labs brought on by Philips that describe the chemicals released by the foam. The reporting team also drew on thousands of complaint reports spanning 13 years that were submitted to a national repository known as the Manufacturer and User Facility Device Experience database. The records are maintained by the Food and Drug Administration and describe reports of patient deaths and injuries as well as device malfunctions. Investigating the Philips Respironics CPAP recall: How we did it | Pittsburgh Post-Gazette RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - TimaaaaaaaahRocks - 10-03-2023 (09-30-2023, 01:03 PM)btreger Wrote: Post-Gazette, ProPublica Allowing a criminal organization to self-regulate itself is obviously detrimental to public health. The harmed resp users should file a class action against the FDA for malfeasance. Going forward the FDA should try actually reading the 510(K)s that come from unethical repeat offenders like respironics with a history of marketing poorly designed and inadequately tested products. Respironics management can't be trusted. The DOJ should investigate FDA's culpability in this matter. And what of the (ir)responsible employees who looked the other way or flew the coop when the realized the company was breaking US law? They get to hide under corporate protection on the back nine at Meadowink. The FDA regulates the medical device industry and categorizes the recall as Class 1, reserved for defects that can cause severe harm or death. - well, actually, NO they do not. Good on the Post Gazette for putting some positive pressure on FDA. (i got a million of 'em ) RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - btreger - 10-06-2023 CDRH Provides Update on Philips June 2021 Recall and Maintains Recommendations Related to Potential Health Risks of PE-PUR Foam The following is attributed to Jeff Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health The FDA remains steadfast in our commitment that patients impacted by the June 2021 recall of certain Philips Respironics ventilators, bilevel positive airway pressure (BiPAP) machines, and continuous positive airway pressure (CPAP) machines deserve relief. While this matter is ongoing, the agency continues to monitor the company's recall progress and share new information with device users, patient care facilities, and other stakeholders. The FDA remains unsatisfied with the status of this recall, and we continue to take steps to protect the health and safety of individuals using these devices. FDA Activities Today, as part of our continued efforts to ensure consumers have the latest information on the Philips recall, the FDA published a new resource section on FDA.gov, including a comprehensive timeline of FDA activities related to the June 2021 recall. Patients, consumers, and healthcare providers have played an integral part in providing feedback to the FDA about the Philips recall, and their feedback is reflected in this new resource to ensure it provides timely and accurate information. CDRH Provides Update on Philips June 2021 Recall and Maintains Recommendations Related to Potential Health Risks of PE-PUR Foam | FDA RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - btreger - 10-06-2023 FIERCE Biotech Still 'unsatisfied’ with Philips' handling of CPAP recall, FDA calls for additional safety testing Since Philips began its recall of millions of respiratory devices in June 2021, the FDA hasn’t been shy about criticizing how the company has handled the recall. This time, the FDA is taking issue with the independent testing Philips commissioned—on a post-recall request from the regulator—to assess the safety of the polyester-based polyurethane (PE-PUR) foam at the heart of the recall. The foam, added to many of Philips’ CPAP and BiPAP machines and ventilators to muffle sound and vibrations, was found to break down over time and possibly release debris and chemicals into a user’s airflow. This week’s rebuke appears to have spooked investors. Its stock price plunged nearly 10% overnight, from a closing price near $20 on Thursday afternoon to below $18 on Friday morning. Additionally, analysts have suggested that the consent decree that’s long been hovering over Philips’ head could soon come crashing down on the company: “The additional testing requirement, continued dissatisfaction of Philips’ handling of the recall and the removal of the device from the shortage list make a Respironics sales ban in the U.S. all the more likely,” a Bernstein analyst wrote this week. FDA 'remains unsatisfied' with Philips' handling of CPAP recall (fiercebiotech.com) RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - eok361 - 10-06-2023 philips will likely be banned from selling anything in the us. i can't say they don't deserve it. they do. it's just too bad that it will lessen both options--and competition--in the field of cpap, and all the other ventilation type machines they produce(d). consumers lose all the way around. RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - Sleeprider - 10-07-2023 Thanks btreger for publishing these summaries and links to articles here. Clearly, consumers (patients) need to be aware of the problems with devices and corporate ethics of the companies that manufacture them. Philips business practices have been questionable for a long time, incentivizing doctors, clinics and institutions to sole-source their devices that clearly are inferior in efficacy. It gets really ugly when the corporate veil is lifted. RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - eok361 - 10-07-2023 (10-07-2023, 08:06 AM)Sleeprider Wrote: Philips business practices have been questionable for a long time, incentivizing doctors, clinics and institutions to sole-source their devices that clearly are inferior in efficacy.it's right up there (lacking in ethics) with purdue. i don't know culpable doctors can be in the philips situation, but the other example is pretty easy to see...imho. RE: RECALL THREAD-- IMPORTANT PHILIPS DREAMSTATION & SYSTEM ONE USERS - Cifer123 - 10-08-2023 [attachment=54885] Hello. Is it safe now to use Philips Respironics DreamStation Expert Auto Canadian version. I found one for sale at half price. The seller says that the old one was replaced with this one. It has not been started or activated. The label in the device îs 21.03.2023. |